Abstract
A method for the synthesis of 4- (1H-benzo[d]imidazole-2-yl)-1-phenyl-1H-1,2,3-triazole-5-amine was developed, and the electronic and spatial structure of this molecule was studied theoretically and experimentally. The study of interaction energies between molecules by quantum-chemical calculations allows us to recognize different levels of crystal structure organization and describe the interaction types causing their formation. The classic N-H…N and C-H…N hydrogen bonds play the main role in all the studied crystals forming the primary basic structural motif. Their role is comparable with the role of the stacking interactions. The molecular docking study predicted that the studied compound may exhibit anti-hepatitis B activity, and experimental in vitro studies confirmed that it is a potent HBV inhibitor with IC50 in a low micromolar range.
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science,General Chemical Engineering
Reference51 articles.
1. Privileged Scaffolds in Medicinal Chemistry. Design, Synthesis, Evaluation;Bräse,2015
2. Nitrogen Containing Privileged Structures and their Solid Phase Combinatorial Synthesis
3. Privileged scaffolds for library design and drug discovery
4. Chemistry and Applications of Benzimidazole and its Derivatives
5. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure–Activity Relationship;Neelima;Arch. Pharm. Chem. Life Sci.,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献